Pharmacotherapy of Osteoarthritis

OA Pharmacotherapy - Pain Game Plan

• Goals: Pain relief, improve function, slow progression?
• Cornerstone: Non-pharmacological (exercise, weight loss) is key.
• Stepwise Approach:
  • Analgesia (Paracetamol $≤$4g/day).
  • NSAIDs (topical/oral, lowest dose/duration). COXIBs for GI risk.
  • IA injections (steroids for flares; hyaluronans - variable).
  • Adjuncts (Duloxetine, Tramadol for refractory pain).

⭐ Weight loss and exercise are crucial non-pharmacological interventions with proven efficacy in OA.

First-Line Responders - Gentle Symptom Soothers

Initial options focus on symptom relief with favorable safety.

NSAIDs - Inflammation Busters Inc.

NSAIDs reduce pain & inflammation by inhibiting Cyclooxygenase (COX) enzymes.

• Mechanism:
  • COX-1: "Housekeeping" enzyme (maintains GI mucosal protection, platelet function, renal blood flow).
  • COX-2: Inducible enzyme (upregulated during inflammation; mediates pain, fever, inflammation).
• Types & Comparison:

• Efficacy: Generally similar for OA symptom relief at equivalent anti-inflammatory doses.
• Strategies to Minimize GI Toxicity:
  • Co-prescription with a Proton Pump Inhibitor (PPI) or Misoprostol.
  • Use the lowest effective dose for the shortest possible duration.
  • Consider COX-2 selective inhibitors in patients at high GI risk but low CV risk.

⭐ All NSAIDs, including selective COX-2 inhibitors, carry a black box warning from the FDA regarding increased risk of serious cardiovascular thrombotic events (including MI and stroke) and serious gastrointestinal adverse events (including bleeding, ulceration, and perforation).

Joint Injections & Other Players - Niche Tactics

• Intra-articular (IA) Corticosteroids (e.g., Triamcinolone, Methylprednisolone)
  • Rapid pain relief (short-term: weeks to months)
  • Indications: Acute flare-ups, severe pain
  • Limit: ≤3-4 injections/year/joint
  • ⚠️ Risk: Chondrotoxicity, infection with frequent use.
• IA Hyaluronic Acid (Viscosupplementation)
  • Mechanism: Restores synovial fluid viscoelasticity, lubrication
  • Delayed onset (weeks), modest, variable benefit
  • Variable guideline recommendations; some do not recommend.

• Comparison: IA Steroids vs. IA Hyaluronic Acid

  Feature	IA Corticosteroids	IA Hyaluronic Acid
  Onset	Rapid	Delayed
  Duration	Weeks-Months	Months
  Use	Acute Flares	Chronic Pain / Mobility
  MOA	Anti-inflammatory	↑Synovial Viscoelasticity

• Symptomatic Slow-Acting Drugs in OA (SYSADOAs)

  • Examples: Glucosamine sulfate/HCl, Chondroitin sulfate. Diacerein inhibits $IL-1\beta$.
  • MOA (general): Proposed chondroprotective & anti-inflammatory.
  • Evidence controversial; slow onset (months), generally well-tolerated.

  ⭐ Diacerein, a SYSADOA, is known for its gastrointestinal side effects, particularly diarrhea, which can limit its clinical utility.

• Other Agents

  • Duloxetine (SNRI): For chronic musculoskeletal pain, including OA, especially with neuropathic component.
  • Topical Capsaicin: Depletes substance P from nerve endings; for localized pain.

High‑Yield Points - ⚡ Biggest Takeaways

• Acetaminophen: First-line analgesic for mild-moderate OA pain.
• NSAIDs (oral/topical): For persistent pain/inflammation; topical NSAIDs preferred for localized OA, fewer systemic effects.
• Intra-articular Corticosteroids: Provide rapid, short-term relief for acute flares.
• Intra-articular Hyaluronic Acid: Viscosupplementation offering modest, delayed benefits.
• Duloxetine: For chronic OA pain, especially with neuropathic features or central sensitization.
• Tramadol: For moderate-severe pain unresponsive to other analgesics.
• Topical Capsaicin: Alternative for localized pain, acts by depleting Substance P; requires regular application for effect and may cause initial burning sensation.